Clinical relevance of FUBP1 to tumor aggressiveness was observed in different cancer types, and the involvement of FUBP1 in prostate cancer was further determined using various databases (Supplemental Figure 1A; supplemental material available online with this article; https://doi.org/10.1172/JCI175023DS1). This evidence concerns the gene FUBP1 and prostate carcinoma.